Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: A systematic review and meta-analysis

Diabetes, Obesity and Metabolism

Volumn 18, Issue 3, 2016, Pages 300-305

  Rohde, U ^a   Hedback N ^a   Gluud, L L ^a   Vilsboll T ^a   Knop, F K ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cholesterol; Duodenal jejunal bypass sleeve (DJBS); EndoBarrier gastrointestinal liner; Fasting plasma glucose; HbA1c; Meta analysis; Obesity; Review; Safety; Type 2 diabetes; Weight loss

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ABDOMINAL PAIN; BODY MASS; BODY WEIGHT; DEATH; DEVICE MIGRATION; DIET THERAPY; DIGESTIVE SURGICAL EQUIPMENT; DUODENAL JEJUNAL BYPASS SLEEVE; ENDOBARRIER GASTROINTESTINAL LINER; EXPLANT; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE BYPASS; LETTER; LIFESTYLE MODIFICATION; MEDICAL DEVICE COMPLICATION; META ANALYSIS; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; WEIGHT REDUCTION; ADULT; ADVERSE EFFECTS; ANALYSIS; BLOOD; COMPLICATION; DEVICES; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; DUODENUM; FEMALE; JEJUNOILEAL BYPASS; JEJUNUM; MALE; MIDDLE AGED; NAUSEA; PROCEDURES; TREATMENT OUTCOME; VOMITING;

ABDOMINAL PAIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DUODENUM; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JEJUNOILEAL BYPASS; JEJUNUM; MALE; MIDDLE AGED; NAUSEA; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VOMITING; WEIGHT LOSS;

EID: 84957846909     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12603     Document Type: Letter

References (31)

1. WHO. Obesity and overweight [Internet]. WHO 2014. Available from URL: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 3 January 2014.
2. Knop FK. Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 2009; 52: 2270-2276.
3. Tarnoff M, Shikora S, Lembo A. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and type 2 diabetes. Surg Endosc 2008; 22: 772-776.
4. Fishman E, Melanson D, Lamport R etal. A novel endoscopic delivery system for placement of a duodenal-jejunal implant for the treatment of obesity and type 2 diabetes. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc 2008: 2501-2503.
5. Montaña R, Slako M, Escalona A. Implantation of the duodenal-jejunal bypass sleeve under conscious sedation: a case series. Surg Obes Relat Dis 2012; 8: e63-e65.
6. Koehestanie P, Betzel B, Dogan K etal. The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation. Surg Endosc 2014; 28: 325-330.
7. Rohde U, Hedbäck N, Gluud LL etal. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies. BMJ Open 2013; 3: e003417.
8. Cochrane Handbook for Systematic Reviews of Interventions. Available from URL: http://handbook.cochrane.org/. Accessed 14 April 2015.
9. Moher D, Liberati A, Tetzlaff J etal. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
10. Rodriguez L, Reyes E, Fagalde P etal. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 2009; 11: 725-732.
11. Tarnoff M, Rodriguez L, Escalona A etal. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009; 3: 650-656.
12. Gersin KS, Rothstein RI, Rosenthal RJ etal. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71: 976-982.
13. Schouten R, Rijs CS, Bouvy ND etal. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010; 251: 236-243.
14. Koehestanie P, de Jonge C, Berends FJ etal. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 2014; 260: 984-992.
15. Rodriguez-Grunert L, Galvao Neto MP, Alamo M etal. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-59.
16. Escalona A, Yáñez R, Pimentel F etal. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis 2010; 6: 126-131.
17. de Moura EGH, Orso IRB, Martins BC etal. Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner. Obes Surg 2011; 21: 941-947. DOI 10.1007/s11695-011-0387-0.
18. de Moura EGH, Martins BC, Lopes GS etal. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2012; 14: 183-189.
19. Escalona A, Pimentel F, Sharp A etal. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 2012; 255: 1080-1085.
20. Cohen RV, Neto MG, Correa JL etal. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab 2013; 98: E279-E282.
21. Krepak Y. EASD virtual meeting [Internet] 2013. Available from URL: http://www.easdvirtualmeeting.org/resources/3698. Accessed 18 May 2015.
22. Koehestanie P, Betzel B, Dogan K etal. The feasibility of delivering a duodenal-jejunal bypass liner (endobarrier) endoscopically with patients under conscious sedation. Surg Endosc 2013; 28: 325-330.
23. Läßle C, Laubner K, Schwacha H etal. Minimally invasive treatment of a duodenal perforation associated with the EndoBarrier duodenal-jejunal bypass liner. Endoscopy 2014; 46(Suppl. 1): UCTN:E171-E172.
24. Segal-Lieberman G. 981 - from.storage. Acute and sub-acute effects of the endobarrier on glucose homeostasis and appetite in obese uncontrolled type 2 diabetes mellitus patients 2015. Available from URL: https://distribute.manage.com/from.storage?image=lMpcSQUmwy3EUk0o73D8b%252fR2Txj8CfNDDXJPej4x3zZPiuzHTXnR0bLvpRT7DUGU1PxTCwLsgiswhV5cOmuf0A%253d%253d. Accessed 18 May 2015.
25. Espinet-Coll E, Pujol-Gebelli J, García-Ruiz-de-Gordejuela A etal. Cholecystitis and duodenal fistula as EndoBarrier®-associated complications. Minimally invasive treatment. Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig 2015; 107: 183-184.
26. Zechmeister-Koss I, Huić M, Fischer S, European Network for Health Technology Assessment (EUnetHTA). The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. Obes Surg 2014; 24: 310-323.
27. Chang S-H, Stoll CRT, Song J etal. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149: 275-287.
28. Sjöström L, Peltonen M, Jacobson P etal. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311: 2297-2304.
29. Schauer PR, Bhatt DL, Kirwan JP etal. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370: 2002-2013.
30. GI Dynamics Announces Results of First Comparative Study of Gastric Bypass and EndoBarrier® Therapy on Diabetes Remission at Digestive Disease Week 2015 [Internet]. Available from URL: http://gidynamics.com/media-press-release.php?id=144. Accessed 22 July 2015.
31. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273: 219-234.